Tirzepatide 30mg*10vials

描述

Core Features
$\ge 99.0\%$ Ultra-High Purity & Batch Consistency: This product is manufactured using industry-leading automated high-throughput Solid-Phase Peptide Synthesis (SPPS) technology. Given that Tirzepatide comprises a complex 39-amino-acid chain and features a challenging-to-control $\text{C}_{20}$ fatty diacid moiety, synthesizing and purifying the 30mg format presents significant technical hurdles. We employ a precise industrial-scale reversed-phase preparative HPLC (RP-HPLC) process to rigorously eliminate by-products such as truncated chains and non-specific side-chain modifications. Each 30mg vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for your research.
Synergistic Twin-Incretin Agonist Mechanism: As an innovative twin-incretin analogue, Tirzepatide binds with high affinity to two key receptors: GIPR (Glucose-dependent Insulinotropic Polypeptide Receptor), which triggers synergistic cascades in adipose tissue, the central nervous system, and pancreatic $\beta$-cells, playing a pivotal role in lipid homeostasis; and GLP-1R (Glucagon-like Peptide-1 Receptor), which effectively regulates glucose-dependent insulin secretion, delays gastric emptying, and modulates feeding behavior. The 30mg fill volume provides an ideal reagent supply for evaluating the synergistic effects of these pathways in long-term in vivo models.
Advanced Cryo-Lyophilization Process: The 30mg high-concentration peptide powder undergoes moisture sublimation at ultra-low temperatures ($-80^\circ\text{C}$) and near-absolute vacuum conditions, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process not only ensures excellent reconstitution properties—allowing for dissolution within seconds—without sediment or bubbles when using sterile water for injection or bacteriostatic water, but also stabilizes the molecule’s secondary structure. This significantly reduces the risk of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters
Parameter
Specification Details
Product Specification: 30 mg / Vacuum-Sealed Glass Vial
Molecular Formula: $\text{C}_{225}\text{H}_{348}\text{N}_{48}\text{O}_{68}$
Appearance: White to off-white sterile lyophilized powder / intact solid cake
Validation: Accompanied by the original manufacturer’s HPLC purity chromatogram and MS molecular weight verification report (one certificate per vial; supports digital traceability and batch verification against manufacturer records).

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Maintain conditions that are light-protected, moisture-proof, and highly vacuum-sealed throughout storage. Do not store in standard household appliances or office equipment lacking temperature logging capabilities. Given the high 30 mg dosage, the product is highly susceptible to degradation after reconstitution; researchers are strongly advised to aliquot and freeze the product based on single-dose animal administration requirements. Repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” protocols. 30mg Tirzepatide is shipped using high-density, reinforced five-layer insulated foam boxes paired with high-capacity, original-manufacturer phase-change gel packs via express delivery. This ensures that the peptide molecules maintain their complex spatial conformation in a “frozen-locked” state while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Tirzepatide 30mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted to academic research within university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., experiments on cell receptor binding affinity, monitoring interventions in rodent metabolic models, etc.). Any non-compliant use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent or performance-enhancing drug/stimulant in sports—is strictly prohibited. This platform enforces a rigorous multi-step review process regarding the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.